University of California - San Diego/Rady Children's Hospital
Welcome,         Profile    Billing    Logout  
 10 Trials 
12 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lee, Stephanie J
NCT04198922: Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease

Recruiting
2
50
US
Acalabrutinib, 1420477-60-6, ACP-196, Benzamide, Bruton Tyrosine Kinase Inhibitor ACP-196, Questionnaire Administration
Fred Hutchinson Cancer Center, AstraZeneca
Recurrent Moderate-Severe Chronic Graft Versus Host Disease, Hematopoietic and Lymphoid Cell Neoplasm
12/25
01/27
NCT05996627: Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

Recruiting
2
82
US
Belumosudil, KD 025, KD-025, KD025, Rho-associated Coiled-coil Kinase 2 Inhibitor KD025, ROCK-II Inhibitor KD025, ROCK2 Inhibitor KD025, SLx 2119, SLx-2119, SLx2119, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Electronic Health Record Review, Placebo Administration
Fred Hutchinson Cancer Center, Sanofi
Chronic Graft Versus Host Disease
05/27
12/27
NCT04111497: Glasdegib for Chronic Graft-Versus-Host Disease

Terminated
1/2
15
US
Glasdegib, 1095173-27-5, PF 04449913, PF-04449913, PF04449913
Fred Hutchinson Cancer Center, Pfizer
Chronic Graft Versus Host Disease, Fasciitis
08/23
08/23
NCT06202677: Effectiveness of a Self-guided Mobile Application in Improving Obsessive Compulsive Disorder Symptoms

Active, not recruiting
N/A
225
RoW
Self-guided program on obsessive compulsive disorder, Self-guided program on cooperation
National University of Singapore, Intellect Pte. Ltd.
Obsessive-Compulsive Disorder
03/24
07/24
Eichenfield, Lawrence F
TARGET-DERM, NCT03661866: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Recruiting
N/A
15000
Europe, Canada, US
Target PharmaSolutions, Inc.
Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria
12/50
12/50
Mesinkovska, Natasha
NCT05551793: Regeneron AA Multicenter (Dupilumab)

Recruiting
2
68
US
Dupilumab, Placebo
Emma Guttman, Regeneron Pharmaceuticals
Alopecia Areata
12/26
12/27
NCT04800185: Characterizing Skin Microbiome Change in Atopic Dermatitis

Completed
1
20
US
Crisaborole 2% Top Oint, Skin Microbiome Swabs
University of California, Irvine, Pfizer
Atopic Dermatitis, Atopic Dermatitis Eczema
04/22
04/22
NCT04969380: SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow

Completed
N/A
20
US
Sofwave
Sofwave Medical LTD
Skin Laxity
02/23
02/23
NCT04530500: COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene Expression

Withdrawn
N/A
200
US
COVID-19 Androgen Sensitivity Test (CoVAST)
University of California, Irvine, Applied Biology, Inc.
Covid19, Androgen Receptor Gene Overexpression
12/21
12/23
TARGET-DERM, NCT03661866: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Recruiting
N/A
15000
Europe, Canada, US
Target PharmaSolutions, Inc.
Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria
12/50
12/50
Haft, Michael
TARGET-DERM, NCT03661866: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Recruiting
N/A
15000
Europe, Canada, US
Target PharmaSolutions, Inc.
Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria
12/50
12/50
Kellogg, Caitlyn
TARGET-DERM, NCT03661866: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Recruiting
N/A
15000
Europe, Canada, US
Target PharmaSolutions, Inc.
Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria
12/50
12/50

Download Options